AR102872A1 - ANTI-PD-1 ANTIBODIES AND THEIR METHODS OF USE - Google Patents

ANTI-PD-1 ANTIBODIES AND THEIR METHODS OF USE

Info

Publication number
AR102872A1
AR102872A1 ARP150103926A ARP150103926A AR102872A1 AR 102872 A1 AR102872 A1 AR 102872A1 AR P150103926 A ARP150103926 A AR P150103926A AR P150103926 A ARP150103926 A AR P150103926A AR 102872 A1 AR102872 A1 AR 102872A1
Authority
AR
Argentina
Prior art keywords
antibodies
methods
bind
treatments
antibody
Prior art date
Application number
ARP150103926A
Other languages
Spanish (es)
Inventor
Youssef Sawsan
Rajpal Arvind
Ute Jooss Karin
Ho Weihsien
Kim Cho Helen
Noubia Abdiche Yasmina
Original Assignee
Rinat Neuroscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rinat Neuroscience Corp filed Critical Rinat Neuroscience Corp
Publication of AR102872A1 publication Critical patent/AR102872A1/en

Links

Abstract

Anticuerpos antagonistas que se fijan a la proteína de muerte celular programada 1 (PD-1) y métodos para usarlos. Los anticuerpos anti-PD-1 se pueden usar terapéuticamente solos o en combinación con otros tratamientos para tratar el cáncer y otras enfermedades. Célula huésped, ADN, vector, método para producir el anticuerpo, composición farmacéutica.Antagonist antibodies that bind to programmed cell death protein 1 (PD-1) and methods to use them. Anti-PD-1 antibodies can be used therapeutically alone or in combination with other treatments to treat cancer and other diseases. Host cell, DNA, vector, method for producing the antibody, pharmaceutical composition.

ARP150103926A 2014-12-09 2015-12-01 ANTI-PD-1 ANTIBODIES AND THEIR METHODS OF USE AR102872A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462089658P 2014-12-09 2014-12-09

Publications (1)

Publication Number Publication Date
AR102872A1 true AR102872A1 (en) 2017-03-29

Family

ID=58672231

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103926A AR102872A1 (en) 2014-12-09 2015-12-01 ANTI-PD-1 ANTIBODIES AND THEIR METHODS OF USE

Country Status (1)

Country Link
AR (1) AR102872A1 (en)

Similar Documents

Publication Publication Date Title
CL2019000061A1 (en) Antibody for anti-claudin 18a2 and its use.
CY1123163T1 (en) ANTIBODIES THAT BIND BETA KLOTHO REGION 2 AND METHODS OF USING THEM
BR112017010762A2 (en) anti-pd-1 antibodies and methods of use
CL2017002244A1 (en) Specific bispecific antibodies for fap and dr5, specific antibodies for dr5 and methods of use. (divisional application 2829-2015).
DOP2018000045A (en) ANTIBODIES PD-L1
EA201890285A1 (en) ANTIBODIES AGAINST PD-1, ACTIVATED ANTIBODIES AGAINST PD-1 AND METHODS OF THEIR APPLICATION
AR105444A1 (en) THERAPEUTIC ANTIBODIES THAT JOIN THE PROTEIN CODIFIED BY THE GENOPHYPE ACTIVATION GEN 3 (LAG3)
CL2018003758A1 (en) Anti-dll3-antibody antibody conjugates and methods of use. (divisional application 201800458)
MY195110A (en) Antibodies to PD-1 and uses Thereof
BR112018002824A2 (en) antibody, polynucleotide, vector, cell, methods to express the antibody, to treat a condition associated with pd-1 and to treat a condition in a subject, kit, pharmaceutical composition and use of the antibody
AR101845A1 (en) ANTI-HER2 AND IMMUNOCUSED ANTIBODIES
CO2019006485A2 (en) Antibodies and methods of their use
AR103488A1 (en) ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BIESPECIFIC ANTIBODIES THAT SPECIFICALLY JOIN CD3 AND / OR CD123
BR112017008914A2 (en) method for treating cancer, makeup and use of makeup
AR105489A1 (en) PD-1 ANTIBODIES
AR107442A1 (en) ANTIBODIES AGAINST THE ORPHANE RECEPTOR SIMILAR TO THE THIROSINE QUINASE 1 (ANTI-ROR1) RECEPTOR, BISPECIFIC ANTIBODIES THAT JOIN ROR1 AND THE CD3 ANTIGEN, AND METHODS FOR TREATMENT OF CANCER
AR103867A1 (en) ANTIBODIES AGAINST IMMUNOGLOBULIN AND DOMAIN 3 CONTAINING MUCINE OF T-CELLS (ANTI-TIM3), USEFUL AS THERAPEUTIC AGENTS
CR20180065A (en) BIESPECTIFIC ANTIBODY CONSTRUCTS THAT JOIN EGFRVIII AND CD3
ECSP19011185A (en) Bispecific antibody-like binding proteins that specifically bind CD3 and CD123
BR112019012354A2 (en) anti-bcma heavy chain antibodies only
CL2016002004A1 (en) Anti-jagged1 antibodies and methods of use
AR115389A1 (en) CD73 ANTAGONIST ANTIBODY
CO2019005101A2 (en) Structural heterodimeric bispecific antibody of natural anti-pd-1 / anti-her2 antibody and method for preparing it
BR112017023131A2 (en) anti-fnc antibodies
AR103726A1 (en) HUMAN ANTI-PD-1 MONOCLONAL ANTIBODY CRYSTALS